Literature DB >> 28257132

The role of rectus muscle myectomy in the management of large-angle strabismus for Graves' ophthalmopathy.

S L Liao1,2, Y-H Wei1, A Y-C Chuang3.   

Abstract

PurposeRetrospective noncomparative case series to investigate the role of rectus muscle myectomy for the treatment of large-angle strabismus in patients with Graves' ophthalmopathy.Patients and methodsData from 47 consecutive patients with Graves' ophthalmopathy who underwent complete myectomy for large-angle strabismus (strabismus greater than 25 prism diopters (PDs)) were collected retrospectively. Pre- and postoperative deviations in primary and reading position were measured in PDs. Postoperative deviation of <5 diopters in primary gaze and functional binocular vision in central 30° field were considered as successful surgical outcomes.ResultsPatients undergoing complete myectomy of the restricted muscles in large-angle strabismus achieved a 78.7% success rate after the first surgery. Reoperation performed on seven patients resulted in 85.7% success rate in reoperation group. The overall success rate was 91.5%. The mean efficacy of the isolated rectus muscle myectomy was 34.3±7.7 PDs.ConclusionsThe complete rectus muscle myectomy technique is effective and predictable in the treatment of large-angle strabismus in patients with Graves' ophthalmopathy.

Entities:  

Mesh:

Year:  2017        PMID: 28257132      PMCID: PMC5519270          DOI: 10.1038/eye.2017.28

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  24 in total

1.  Tenon recession: a novel adjunct to improve outcome in the treatment of large-angle strabismus in thyroid eye disease.

Authors:  Christopher I Zoumalan; Gary J Lelli; Michael Kazim
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2011 Jul-Aug       Impact factor: 1.746

2.  Correction of restricted extraocular muscle motility in surgical management of strabismus in graves' ophthalmopathy.

Authors:  Vu Thuy Nguyen; Dong Jun John Park; Lori Levin; Steven E Feldon
Journal:  Ophthalmology       Date:  2002-02       Impact factor: 12.079

3.  Strabismus surgery for endocrine ophthalmopathy.

Authors:  F D Ellis
Journal:  Ophthalmology       Date:  1979-12       Impact factor: 12.079

4.  Extraocular muscle surgery for Graves' ophthalmopathy: does prior treatment influence surgical outcome?

Authors:  M P Mourits; L Koorneef; A M van Mourik-Noordenbos; H M van der Meulen-Schot; M F Prummel; W M Wiersinga; A Berghout
Journal:  Br J Ophthalmol       Date:  1990-08       Impact factor: 4.638

5.  Long-term results of adjustable suture surgery for strabismus secondary to thyroid ophthalmopathy.

Authors:  G T Lueder; W E Scott; P J Kutschke; R V Keech
Journal:  Ophthalmology       Date:  1992-06       Impact factor: 12.079

6.  Ophthalmic surgery in dysthyroid ophthalmopathy.

Authors:  Yoichi Inoue; Toshikazu Tsuboi; Ai Kouzaki; Toshine Maeda; Toyoko Inoue
Journal:  Thyroid       Date:  2002-03       Impact factor: 6.568

7.  Diagnosis and treatment of thyroid myopathy.

Authors:  W E Scott; J A Thalacker
Journal:  Ophthalmology       Date:  1981-06       Impact factor: 12.079

8.  The characteristics and surgical outcomes of medial rectus recessions in Graves' ophthalmopathy.

Authors:  Mehmet C Mocan; Christine Ament; Nathalie F Azar
Journal:  J Pediatr Ophthalmol Strabismus       Date:  2007 Mar-Apr       Impact factor: 1.402

Review 9.  Diagnostic criteria for Graves' ophthalmopathy.

Authors:  G B Bartley; C A Gorman
Journal:  Am J Ophthalmol       Date:  1995-06       Impact factor: 5.258

10.  Diagnosis and surgical management of strabismus associated with thyroid-related orbitopathy.

Authors:  M Flanders; M Hastings
Journal:  J Pediatr Ophthalmol Strabismus       Date:  1997 Nov-Dec       Impact factor: 1.402

View more
  1 in total

1.  Sequential changes in intraocular pressure during strabismus surgery in patients with thyroid eye disease.

Authors:  Areum Jeong; Won Jae Kim
Journal:  BMC Ophthalmol       Date:  2022-03-18       Impact factor: 2.209

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.